Tencent’s popularity may help it avoid trouble with Beijing. But its vast power could still squelch innovation in the world’s largest online market.
Tag: Regulation and Deregulation of Industry
Moderna Seeks Full F.D.A. Approval for Covid Vaccine
The company’s application follows the move by Pfizer and BioNTech to seek full approval last month. The vaccines already have emergency use authorization in the United States.
Pakistan’s Private Vaccinations Draw Criticism
An inoculation push, plagued with limited supplies and red tape, makes doses available to those who can pay for them. In a country with a struggling economy, most can’t.
China’s Biggest ‘Bad Bank’ Tests Beijing’s Resolve on Financial Reform
Chinese regulators say they want to clean up the country’s financial system, but a state-owned conglomerate may ultimately get in the way.
Nick Clegg Steers Facebook’s Trump Decision
Nick Clegg, a former deputy prime minister, has shaped the company’s handling of Donald Trump at every turn.
Jack Ma Shows Why China’s Tycoons Keep Quiet
High-profile business leaders have been detained, sidelined or silenced as the Communist Party moves forcefully to keep companies in line. Today, the best strategy is to lie low.
A Global Tipping Point for Reining In Tech Has Arrived
Never before have so many countries, including China, moved with such vigor at the same time to limit the power of a single industry.
How Worried Should You Be About the J&J Vaccine and Blood Clots?
Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson & Johnson vaccine while it investigates extremely rare blood clots.
White House Warns of Johnson & Johnson Vaccine Scarcity
Johnson & Johnson will allocate 86 percent fewer doses across the United States next week than are now being allocated, according to C.D.C. data, dealing a setback to a national vaccination campaign that has just found its footing.